Atea Pharmaceuticals (AVIR) Shares Issued (2021 - 2026)
Atea Pharmaceuticals (AVIR) recorded quarterly Shares Issued of $871000.0 in Q1 2026, up 1282.54% quarter-over-quarter from $63000.0 in Q3 2025, and up 531.16% on a YoY basis from $138000.0 in Q1 2025.
Atea Pharmaceuticals (AVIR) Shares Issued (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Shares Issued history runs 6 years deep, the most recent figure standing at $871000.0 for Q1 2026.
- In Q1 2026, Shares Issued rose 531.16% year-over-year to $871000.0; the TTM figure through Mar 2026 stood at $934000.0 (up 266.27% YoY), while the FY2025 annual figure was $201000.0, down 24.72% from the prior year.
- Shares Issued was $871000.0 for Q1 2026 at Atea Pharmaceuticals, up from $63000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $871000.0 in Q1 2026 to a low of -$83000.0 in Q3 2022.
- Historically, Shares Issued has averaged $182600.0 across 5 years, with a median of $127500.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Shares Issued slumped 110.44% in 2022, then surged 531.16% in 2026.
- A 5-year view of Shares Issued shows it stood at $90000.0 in 2022, then advanced by 2.22% to $92000.0 in 2023, then rose by 27.17% to $117000.0 in 2024, then sank by 46.15% to $63000.0 in 2025, then soared by 1282.54% to $871000.0 in 2026.
- The last three Shares Issued figures came in at $871000.0 (Q1 2026), $63000.0 (Q3 2025), and $138000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26,927.15 |
| 10 | Atea Pharmaceuticals | 347.28 Mn | 347.28 Mn | - | 871,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 871,000.00 |
| Mar 31, 2026 | 871,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | -83,000.00 |
| Sep 30, 2022 | -83,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Mar 31, 2022 | 223,000.00 |